 |
- Life Technologies' MicroSEQ® Real-Time PCR workflows approved as method for testing Australian export meat and meat products
MELBOURNE, Australia, December 16, 2013 /PRNewswire/ -- Life Technologies Corporation (NASDAQ:LIFE) today announced that its MicroSEQ® Real-Time PCR workflow was officially approved by the Australian Government, Department of Agriculture as an Approved Test Method to detect pathogens in export meat and meat products.
Australia is a major exporter of food and the second largest exporter of beef in the world. When exporting food, many products are subject to testing as part of the trade arrangements between Australia and importing countries. Many countries require test methods under their country's regulation including methods that are prior to the approval by the government of Australia. Therefore, microbiological testing which is commonly agreed by both exporting and importing countries following government approved methods at regulated laboratories is essential to ensure the quality of the export products.
The Department of Agriculture in Australia has reviewed the validation data and granted approval for the use of the Life Technologies' MicroSEQ® Real-Time PCR workflows for the testing of Australian meat and meat products for export. The workflows approved are used to detect three pathogens, E. coli O157:H7 (in raw ground beef and beef trim), Salmonella and Listeria monocytogenes (in meat and meat products), which are the major food pathogens associated with meats and meat products. The approved total workflows include use of PrepSEQ™ Rapid Spin Sample Preparation Kit or Automated PrepSEQ™ Nucleic Acid Extraction Kit, MicroSEQ® Detection Kits and 7500 Fast Real-Time PCR Instrument, guided by the RapidFinder™ Express Software to gain data.
"We believe that this approval warrants our dedication as a global leader to food safety." said Gerard Davis, Director of Animal Health, Food Safety & Environment, Asia Pacific and Japan region of Life Technologies. "We are committed to offer integrated solutions to provide faster, accurate and innovative technologies to food producers, service labs and governments in every region across the globe."
"Grounded in the community, we offer wide solutions to researchers and institutions in fields such as Life Science, Medical Science, Food and Animal Safety and Forensics" said Owen Wright, General Manager of Australia and New Zealand of Life Technologies. "We are glad that with our global expertise, we could contribute to the Australian and global food industry."
Summary of Methodologies for these products are available on the Department of Agriculture's website.
About Life Technologies
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company that is committed to providing the most innovative products and services to leading customers in the fields of scientific research, genetic analysis and applied sciences. With a presence in more than 180 countries, the company's portfolio of 50,000 end-to-end solutions is secured by more than 5,000 patents and licenses that span the entire biological spectrum————scientific exploration, molecular diagnostics, 21st century forensics, regenerative medicine and agricultural research. Life Technologies has approximately 10,000 employees and had sales of $3.8 billion in 2012.
Life Technologies' Safe Harbor Statement
This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.
Life Technologies Media Contact:
Atsuko Igawa
Tel:+81-36832-9446
atsuko.igawa@lifetech.com
